BN Business News
Add your company to Business Communicator →

Business · 18/07/1995Updated: 10/18/2026 · 1 min read

FDA to Hold Public Hearing on Regulation of Living Autologous Cell Products for Implantation

Summary

The FDA is hosting a public hearing to gather input on the regulation of products containing living autologous cells, which are manipulated outside the body and used for structural repair or reconstruction, including cosmetic applications.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →